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Introduction: Splenoma or splenic hamartoma is a rare primary splenic tumor most often discovered radiologically
and incidentally. Splenic hamartomas have a strong association with solid and hematological malignancies and, in
rare cases, with tuberous sclerosis, but to the best of our knowledge no reports of splenic hamartomas associated
with familial adenomatous polyposis have been documented, although it is recognized that familial adenomatous
polyposis presents a variety of extracolonic manifestations.
Case presentation: We report on a very rare case of multiple splenic hamartomas in a 46-year-old white woman
who had previously undergone surgery for restorative proctocolectomy for familial adenomatous polyposis. A computed
tomography scan of her spleen revealed multiple small lesions which measured less than 1cm in diameter. A
splenectomy was performed and a histologic examination of the splenectomy specimen revealed the presence
of multiple hamartomas.
Conclusion: Incidence, differential diagnosis, diagnostic procedures, pathologic findings and treatment of splenic
hamartomas are discussed here and hamartomas are considered in a differential diagnosis of splenic tumors. A
splenectomy is indicated in cases where malignancy cannot be excluded and in cases of associated hematologic
disorders. To the best of our knowledge our patient is the first reported case to have splenic hamartomas identified in
a familial adenomatous polyposis-affected patient with mutation in exon 15 of the APC gene. At this time it is not
possible to correlate with certainty our multiple splenic hamartomas and familial adenomatous polyposis case as a
clinical manifestation of the mutation of APC gene; however, we believe that this case report could be important
for further observation of similar cases in the future.
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Splenic hamartomas (SHs), also known as splenomas,
accessory spleens in the spleen, congenital malformation
and hyperplastic nodules, are rare benign vascular prolif-
erative tumors with an anomalous mixture of normal
splenic elements such as red and white pulp, and are
characterized by cluster of differentiation (CD) 8 immu-
nopositivity of the vascular endothelial lining cells [1–3].* Correspondence: nicola.anita@tiscali.it
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creativecommons.org/publicdomain/zero/1.0/Their diagnosis is often incidental at autopsy or when
evaluating images for other reasons [1].
Although benign, it is imperative that a differential
diagnosis be made between splenic primary and second-
ary malignancies [1, 4].
Here we report on a rare case of multiple SHs inciden-
tally found in a woman who had previously been oper-
ated on for familial adenomatous polyposis (FAP) coli.Case presentation
A 46-year-old white woman was admitted for the pres-
ence of small multiple splenic lesions which wereess article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Fig. 2 a Haphazardly arranged slit-like vascular process without
intervening white pulp. Hematoxylin and eosin staining, ×200. b Vascular
spaces lined by plump endothelial cells without atypia and containing
red blood cells. Hematoxylin and eosin staining, ×400
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tomography (CT) scan. At the scan she was found to
have an incisional hernia at the midline incision of the
previous colectomy. She was asymptomatic with unre-
markable laboratory findings. On physical examination,
no palpable mass in her abdomen was found. Upper and
lower endoscopy and abdominal ultrasonography (US)
did not show primary malignancies, while the CT scan
(Fig. 1) revealed a dysmorphic and inhomogeneous
spleen with nodular millimeter hypodense areas which
were found to be almost isodense to the remaining
splenic parenchyma in basic and later contrastographic
scans (Additional file 1).
She had a 20-year history of FAP of a classic pheno-
type with profuse colorectal polyposis. She had succes-
sively undergone a restorative proctocolectomy (1995),
exeresis of cranial osteomas (2003), hysteroannessect-
omy for a benign ovarian cyst and uterine myomatosis
(2007), and has been regularly followed up. She also pre-
sented congenital hypertrophy of retinal pigment epithe-
lium (CHRPE) and dental abnormalities. On mutational
analysis, a mutation of the adenomatous polyposis coli
(APC) gene in fragment C of exon 15, deletion of an A
nucleotide (c.2638delA) was found which created a pre-
mature stop codon 105 nucleotides downstream and
caused a truncated protein (p.Ile880SerfsX36).
A few days following the scan, she underwent a lapar-
otomy with splenectomy and incisional hernia repair.
Her postoperative course was uneventful and she was
discharged on the seventh postsurgical day.
Histological examination of the specimen (Figs. 2 and 3)
revealed SHs.
The resected spleen measured 10×8×2cm and, on the
cut section, showed multiple well-circumscribed bulging
nodules ranging in size from 0.5cm to 1cm. These were
red-tan, quite homogeneous and compressing the sur-
rounding splenic parenchyma. On microscopic examin-
ation, the lesions were composed of disorganized cordsFig. 1 Dysmorphic and inhomogeneous spleen, with nodular
millimeter areas – indicated with the arrows - which appeared
hypodense during arterial and portal phases of the contrastographic
study (transverse diameter max 11mm at abdominal CT scan)and sinuses of red pulp with slit-like vascular spaces
lined by plump endothelial cells containing erythrocytes
and, occasionally, an amorphous material largely com-
posed of trapped platelets. White pulp follicles were ab-
sent and only a scant trabecular structure was observed.
No cytological atypia was observed. Although grossly
well demarcated, the nodules were not capsulated, but
surrounded by a rim of compressed red pulp separating
them from the normal spleen without associated fibrosis.
The residual spleen was histologically unremarkable.
On immunohistochemical examination, the endothe-
lial cells lining the vascular channel were positive for
CD8, CD31, CD34 and vimentin. The definitive diagno-
sis was multiple hamartomas of the spleen.
After the operation at a six-month follow-up, she was
in good general health.
Subsequent to further analysis, we have confirmed
the presence of the heterozygous mutation c2638delA
in exon 15 of the APC gene, also on the DNA ex-
tracted from a paraffin-embedded specimen of the
SHs (Fig. 4).
Fig. 3 c The nodule was composed of disorganized red pulp elements and was separated from the normal spleen by a compressed rim of tissue
and not by a true capsule or fibrosis. Hematoxylin and eosin staining, ×100. The endothelial cells lining the vascular spaces are positive for: a CD8,
b vimentin, and d CD31. Immunohistochemical staining, ×100
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This rare case of multiple SHs with FAP led us to review
the literature and to considerations on incidence, diag-
nosis, pathologic findings and treatment of SHs, in order
to try to understand their likely association with FAP.
While splenic tumors are uncommon, benign ones are
extraordinarily rare (7/100,000 autopsy specimens) [5].
Rokitansky [6] first described a SH under the appellation
of splenomas; since then, more than 150 cases have been
reported with a prevalence of 0.024 to 0.13 % given in a
review of autopsies [7] and three in 200,000 splenecto-
mies [3].
The origin of SH is not clear with some hypotheses in-
cluding congenital malformations of the splenic red
pulp, neoplasms of the splenic red pulp, post-traumatic
reactive lesions [3, 8] or acquired proliferative processes
as documented in cases associated with hematological
malignancies [4].
SHs may be associated with solid and hematological
malignancies (that is, thymomas, squamous cell carcin-
omas and renal cell carcinomas) and in rare cases with
tuberous sclerosis, an autosomal dominant disorder
characterized by the development of benign tumors
(hamartomas) in multiple organs (that is, brain, skin,
lungs and kidneys) [1, 2].
Our case concerns a woman who received a molecular
diagnosis of FAP. FAP is a dominant inherited autosomal
disorder associated with mutations in the APC gene. Inaddition, bi-allelic mutations in the MYH gene may ac-
count for up to 30 % of families with multiple adenomas
(15–100) which do not exhibit an autosomal dominant
pattern of inheritance nor a germline mutation in the
APC gene [9]. A variety of extracolonic manifestations
(ECM) occur in patients with FAP and many of them
could correlate to a specific mutation of the APC gene
[10] (Table 1).
In a review of the medical literature, no reported asso-
ciation between FAP and SHs has yet been made. In
addition, in hamartomatous polyposis syndromes, such
as Peutz–Jeghers syndrome (PJS) an autosomal domin-
ant syndrome arising from germline mutations in the
serine threonine kinase gene (STK11) [11], SHs have not
been identified although an exceptionally high rate of
extracolonic cancers in patients with PJS including gas-
tric (29 %), small bowel (13 %), pancreatic (36 %), breast
(54 %), ovarian (21 %), lung (15 %), cervical (10 %), and
uterine/testicular (9 %) [12] and many other benign le-
sions [13] were reported.
Nor was SH reported among numerous clinical mani-
festations [14] of hamartoma tumor syndrome, an auto-
somal disorder associated with germline mutation or a
differential expression of phosphatase and tensin homo-
log gene (PTEN) on chromosome ten [15, 16].
In our patient a profuse FAP was diagnosed back in
1995 and a restorative proctocolectomy was performed.
She presented several ECM: osteoma, dental anomalies,
Fig. 4 c.2638delA APC mutation detection on DNA extracted from a paraffin-embedded specimen of the splenic hamartoma. a Denaturing high-
performance liquid chromatography and b sequencing analysis of amplified product corresponding to DNA region including the mutation
c.2638delA of APC gene. a is carrier patient; b is normal control; c is the position of mutation, c.2638delA (the forward sequence is shown)
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lar analysis a mutation of the APC gene [17] was found in
fragment C of exon 15, the deletion of an A nucleotide
(c.2638delA) which determined a frameshift and therefore a
premature stop codon, 105 nucleotides downstreamTable 1 Genotype/Phenotype correlations of extracolonic
manifestations in patients with familial adenomatous polyposis
and attenuated familial adenomatous polyposis
Phenotype Exon of APC gene Codon position
Papillary thyroid carcinoma 3–15 exons Codons 140–1309
Hepatoblastoma 3–15 exons Codons 141–1578
Congenital hypertrophy of retinal
pigment epithelium (CHRPE)
10–15 exons Codons 463–1445
Osteomas 15 exon Codons 767–1578
Desmoids 15 exon Codons 1309–1580causing the truncated protein (p.Ile880SerfsX36). This
mutation was also identified in heterozygous on DNA
extracted from the paraffin-embedded specimen of the
SH. As expected, loss of heterozygosity (LOH) of the
APC gene was not present and was consistent with the
benign nature of the hamartomatous tumor [18].
Moreover, all carriers in her family presented a classic
FAP phenotype with profuse polyposis of the colorectum
and had undergone restorative proctocolectomies in the
third decade of their lives. Mutations in exon 15 are
common in affected patients with FAP and are associ-
ated with profuse polyposis and some ECM.
A correlation between the mutation site and clinical
phenotype encompassing both colonic and repeatedly
extracolonic features has been reported [19, 20]. Muta-
tions at codon 1309 lead to the most severe intestinal
phenotype characterized by a high number and early
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that SHs are included among extracolonic manifestations.
SHs vary in size and sometimes can reach 20cm in
diameter. Two histological types exist according to the
tumor components [3]: a white pulp type and a red pulp
type. The white pulp type is composed entirely of
lymphoid tissue, while the red pulp type is composed of
an aberrant complex of sinuses. Most tumors are a mix-
ture of the two subtypes. Their characteristic histological
features are disorganized vascular channels lined with
plump endothelial cells. The lining cells of the vascular
channels are typically positive for CD8, CD31, CD34,
factor-related antigen and vimentin [1, 2, 21]. Immunohis-
tochemical staining may distinguish a SH from a capillary
hemangioma according to their respective staining charac-
teristics. Endothelial cells which are positive for CD8 are a
key feature that distinguishes a hamartoma from other
vascular lesions of the spleen [1, 21, 22]. The endothelial
cells of SHs are CD8-positive in contrast with the CD8-
negative of hemangiomas [22].
As in our case, the majority of patients (80 %) with
hamartomas do not have any symptoms and an inciden-
tal diagnosis is made during autopsy or an image evalu-
ation [2]. In the other cases splenomegaly, palpable
mass, spontaneous rupture of the spleen, anemia,
thrombocytopenia and digestive symptoms may allow
for identification [1, 23].
The diagnosis of hamartomas can be a challenge as it
is difficult to distinguish them from splenic primary ma-
lignancies with imaging modalities [22]. CT scans and
US features have been highly variable and nonspecific.
Recently, the radiological features on US, color Doppler
imaging, CT and magnetic resonance imaging (MRI)
have been able to clearly identify hamartomas [23]. Such
tumors may appear hyperechoic on US, or as isodense
or hypodense solid masses relative to the adjacent nor-
mal splenic parenchyma on CT. On color Doppler the
blood flow results are increased due to hypervascularity.
The main differential diagnosis includes other vascular
tumors and solid mass-forming lesions (hemangioma,
littoral cell angioma, lymphangioma, hemangioendothe-
lioma, sclerosing angiomatoid nodular transformation,
angiosarcoma inflammatory myofibroblastic tumor,
lymphoma and metastatic tumors) [1, 23]. Once identi-
fied, a pathological examination is strongly needed. The
risk of bleeding or tumor dissemination makes a fine
needle aspiration biopsy of the spleen problematic [22]
and therefore surgery is necessary for diagnostic and
therapeutic purposes.
Once a splenic lesion is discovered, a malignant tumor
cannot be ruled out without performing a splenectomy.
A splenectomy may be curative even for hematological
disorders associated with hamartomas. Although re-
cently laparoscopic surgery has become the standardtechnique for splenic disorders, due to our patient’s pre-
vious colectomy, we adopted a laparotomic approach
due to the presence of several tenacious intraperitoneal
adherences.
Conclusions
SHs are benign vascular proliferative lesions with a char-
acteristic CD8-positive immunophenotype of the lining
endothelial cells. A splenectomy is mandatory to exclude
primary or secondary malignancies. To the best of our
knowledge, this is the first reported SH case identified in
a FAP-affected patient with mutation in exon 15 of the
APC gene. We therefore feel that the topic of this report
could be relevant for further observation of similar cases
in the future.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
Additional file
Additional file 1: 46 years old FAP affected patient with splenic
hamartomas: main steps of her clinical history.
Abbreviations
APC: Adenomatous polyposis coli; CD: Cluster of differentiation; CHRPE: Congenital
hypertrophy of retinal pigment epithelium; CT: Computed tomography;
ECM: Extracolonic manifestations; FAP: Familial adenomatous polyposis;
PJS: Peutz–Jeghers syndrome; SH: Splenic hamartoma; US: Ultrasonography.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
NC, MLC, MC, and AC treated the patient, collected the data, reviewed the
literature and wrote the paper. FD and MDR performed the molecular
analysis. VV and GC performed the pathology analysis. NC and MLS carried
out critical interpretations. All authors read and approved the final
manuscript.
Acknowledgement
Ms Juliet Ippolito BA, Vassar College, MPhil University of Dundee, for English
language editing.
Prof. Guido Pettinato, Ordinary Professor of Pathology gave us a substantial
contribution in performing histologic studies and immunohistochemistry
and critically revised the manuscript for important intellectual content.
Prof. Paola Izzo, Ordinary Professor of Biochemistry, Chief of Molecular
Medicine and Medical Biotechnology Dept. and CEINGE-Biotecnologie
Avanzate – University Federico II of Naples, gave us a substantial contribution in
performing molecular analysis and critically revised the manuscript for important
intellectual content.
Prof. Andrea Renda, Ordinary Professor of Surgery of University Federico II of
Naples critically revised the manuscript for important intellectual content.
Author details
1General Surgery Unit – Advanced Biomedical Science Department,
University Federico II of Naples, Via S. Pansini 5, 80131 Naples, Italy.
2Molecular Medicine and Medical Biotechnology Department, University
Federico II of Naples, Naples, Italy. 3Advanced Biomedical Science
Department, University Federico II of Naples, Naples, Italy.
Carlomagno et al. Journal of Medical Case Reports  (2015) 9:154 Page 6 of 6Received: 20 January 2015 Accepted: 25 May 2015References
1. Lee H, Maeda K. Hamartoma of the spleen. Arch Pathol Lab Med.
2009;133:147–51 [PMID: 19123729 doi:10.1043/1543-2165-133.1.147].
2. Ali TZ, Beyer G, Taylor M, Volpe C, Papadimitriou JC. Splenic
hamartoma: immunohistochemical and ultrastructural profile of two
cases. Int J Surg Pathol. 2005;13:103–11 [PMID: 15735864 doi:10.1177/
106689690501300116].
3. Silverman ML, LiVolsi VA. Splenic hamartoma. Am J Clin Pathol. 1978;70:224–9.
PMID: 696681.
4. Abbott RM, Levy AD, Aguilera NS, Gorospe L, Thompson WM. From the
archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-
pathologic correlation. Radiographics. 2004;24:1137–63 [PMID: 15256634
doi:10.1148/rg.244045006].
5. Moriyama S, Inayoshi A, Kurano R. Inflammatory pseudotumor of the spleen:
report of a case. Surg Today. 2000;30:942–6.
6. Rokitansky K: About splenomas. Lehrbuch der Pathologishen Anatomie.
Baud 1. 1861, p 3.
7. Lam KY, Yip KH, Peh WC. Splenic vascular lesions: unusual features and a
review of the literature. Aust NZJ Surg. 1999;69:422–5. PMID: 10392884.
8. Sankar S, Thanka J, Jagdishchandrabose S, Rajendran S. Splenic hamartoma:
a rare vascular space occupying lesion of the spleen. Indian J Pathol
Microbiol. 2011;54:223–5 [PMID: 21393931 doi:10.4103/0377-4929.77416].
9. De Rosa M, Galatola M, Borriello S, Duraturo F, Masone S, Izzo P. Implication
of adenomatous polyposis coli and MUTYH mutations in familial colorectal
polyposis. Dis Colon Rectum. 2009;52(2):268–74. doi:10.1007/
DCR.0b013e318197d15c.
10. De Rosa M, Dourisboure RJ, Morelli G, Graziano A, Gutiérrez A, Thibodeau S,
et al. First genotype characterization of Argentinean FAP patients:
identification of 14 novel APC mutations. Hum Mutat. 2004;23(5):523–4.
11. Resta N, Simone C, Mareni C, Montera M, Gentile M, Susca F, et al. STK11
mutations in Peutz-Jeghers syndrome and sporadic colon cancer. Cancer
Res. 1998;58(21):4799–801.
12. Patel SG, Ahnen DJ. Familial colon cancer syndromes: an update of a rapidly
evolving field. Curr Gastroenterol Rep. 2012;14(5):428–38. doi:10.1007/
s11894-012-0280-6.
13. Schreibman IR, Baker M, Amos C, McGarrity TJ. The hamartomatous
polyposis syndromes: a clinical and molecular review. Am J Gastroenterol.
2005;100(2):476–90.
14. Stanich PP, Pilarski R, Rock J, Frankel WL, El-Dika S, Meyer MM. Colonic
manifestations of PTEN hamartoma tumor syndrome: case series and
systematic review. World J Gastroenterol. 2014;20(7):1833–8.
15. Galatola M, Paparo L, Duraturo F, Turano M, Rossi GB, Izzo P, et al. Beta
catenin and cytokine pathway dysregulation in patients with manifestations
of the “PTEN hamartoma tumor syndrome”. BMC Med Genet. 2012;13:28.
doi:10.1186/1471-2350-13-28.
16. Paparo L, Rossi GB, Delrio P, Rega D, Duraturo F, Liccardo R, et al.
Differential expression of PTEN gene correlates with phenotypic
heterogeneity in three cases of patients showing clinical manifestations of
PTEN hamartoma tumour syndrome. Hered Cancer Clin Pract. 2013;11(1):8.
17. Scarano MI, De Rosa M, Panariello L, Carlomagno N, Riegler G, Rossi GB,
et al. Familial adenomatous polyposis coli: five novel mutations in exon 15
of the adenomatous polyposis coli (APC) gene in Italian patients. Mutations
in brief no. 225. Online. Hum Mutat. 1999;13(3):256–7.
18. Yeung AT, Patel BB, Li XM, Seeholzer SH, Coudry RA, Cooper HS, et al. One-
hit effects in cancer: altered proteome of morphologically normal colon
crypts in familial adenomatous polyposis. Cancer Res. 2008;68(18):7579–86.
19. Panariello L, Scarano MI, de Rosa M, Capasso L, Renda A, Riegler G, et al.
hMLH1 mutations in hereditary nonpolyposis colorectal cancer kindreds.
Mutations in brief no. 182. Online. Hum Mutat. 1998;12(3):216–7.
20. Scarano MI, De Rosa M, Gentile M, Bucci L, Ferulano GP, Carlomagno N,
et al. Three novel germline mutations in the adenomatous polyposis coli
gene. Hum Mutat. 1997;9(2):191–3.
21. Zukerberg LR, Kaynor BL, Silverman ML, Harris NL. Splenic hamartoma and
capillary hemangioma are distinct entities: immunohistochemical analysis of
CD8 expression by endothelial cells. Hum Pathol. 1991;22:1258–61. PMID:
1748432.22. Namikawa T, Kitagawa H, Iwabu J, Kobayashi M, Matsumoto M, Hanazaki K.
Laparoscopic splenectomy for splenic hamartoma: case management and
clinical consequences. World J Gastrointest Surg. 2010;2(4):147–52.
23. Wang JH, Ma XL, Ren FY, Zuo CJ, Tian JM, Wang ZF, et al. Multi-modality
imaging findings of splenic hamartoma: a report of nine cases and review
of the literature. Abdom Imaging. 2013;38:154–62 [PMID: 22539044
doi:10.1007/s00261-012-9880-8].Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
